Cas no 39115-22-5 (1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)-)
1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)- Chemical and Physical Properties
Names and Identifiers
-
- 1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)-
- 4-(4-hydroxy-3-methoxyphenyl)butane-1,2-diol
- 39115-22-5
- AKOS040762925
-
- Inchi: 1S/C11H16O4/c1-15-11-6-8(3-5-10(11)14)2-4-9(13)7-12/h3,5-6,9,12-14H,2,4,7H2,1H3
- InChI Key: QRLKUDTXXCQFMV-UHFFFAOYSA-N
- SMILES: OC(CO)CCC1C=CC(=C(C=1)OC)O
Computed Properties
- Exact Mass: 212.10488
- Monoisotopic Mass: 212.10485899g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 15
- Rotatable Bond Count: 5
- Complexity: 174
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 1
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.2
- Topological Polar Surface Area: 69.9?2
Experimental Properties
- Density: 1.2±0.1 g/cm3
- Boiling Point: 430.9±45.0 °C at 760 mmHg
- Flash Point: 214.4±28.7 °C
- PSA: 69.92
- Vapor Pressure: 0.0±1.1 mmHg at 25°C
1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)- Security Information
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Safety Instruction: H303+H313+H333
- Storage Condition:Store at 4 ℃, better at -4 ℃
1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TargetMol Chemicals | TN5772-5mg |
4-(4-Hydroxy-3-methoxyphenyl)butane-1,2-diol |
39115-22-5 | 5mg |
¥ 3710 | 2024-07-20 | ||
| TargetMol Chemicals | TN5772-5 mg |
4-(4-Hydroxy-3-methoxyphenyl)butane-1,2-diol |
39115-22-5 | 98% | 5mg |
¥ 3,710 | 2023-07-11 | |
| TargetMol Chemicals | TN5772-1 mL * 10 mM (in DMSO) |
4-(4-Hydroxy-3-methoxyphenyl)butane-1,2-diol |
39115-22-5 | 98% | 1 mL * 10 mM (in DMSO) |
¥ 3810 | 2023-09-15 | |
| TargetMol Chemicals | TN5772-1 ml * 10 mm |
4-(4-Hydroxy-3-methoxyphenyl)butane-1,2-diol |
39115-22-5 | 1 ml * 10 mm |
¥ 3810 | 2024-07-20 | ||
| TargetMol Chemicals | TN5772-5mg |
4-(4-Hydroxy-3-methoxyphenyl)butane-1,2-diol |
39115-22-5 | 5mg |
¥ 3710 | 2024-07-24 | ||
| TargetMol Chemicals | TN5772-1 ml * 10 mm |
4-(4-Hydroxy-3-methoxyphenyl)butane-1,2-diol |
39115-22-5 | 1 ml * 10 mm |
¥ 3810 | 2024-07-24 |
1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)- Related Literature
-
Vishwesh Venkatraman,Marco Foscato,Vidar R. Jensen,Bj?rn K?re Alsberg J. Mater. Chem. A, 2015,3, 9851-9860
-
Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
-
Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082
-
Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
Additional information on 1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)-
Recent Advances in the Study of 1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)- (CAS: 39115-22-5) in Chemical Biology and Pharmaceutical Research
The compound 1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)- (CAS: 39115-22-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique phenolic and diol structural features, has demonstrated promising biological activities, including antioxidant, anti-inflammatory, and potential anticancer properties. Recent studies have focused on elucidating its mechanism of action, optimizing its synthesis, and exploring its therapeutic applications.
One of the key areas of investigation has been the compound's role as a precursor or intermediate in the synthesis of more complex bioactive molecules. Researchers have reported efficient synthetic routes to produce 1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)- with high yield and purity, which is critical for its application in drug development. Advanced spectroscopic techniques, including NMR and mass spectrometry, have been employed to confirm its structural integrity and purity.
In vitro studies have revealed that this compound exhibits significant antioxidant activity, scavenging free radicals and reducing oxidative stress in cellular models. These findings suggest its potential utility in treating diseases associated with oxidative damage, such as neurodegenerative disorders and cardiovascular diseases. Additionally, preliminary data indicate that it may modulate inflammatory pathways, making it a candidate for further investigation in autoimmune and chronic inflammatory conditions.
Recent pharmacological evaluations have also explored its anticancer potential. Studies using cancer cell lines have shown that 1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)- can induce apoptosis and inhibit proliferation in certain types of cancer cells. These effects are believed to be mediated through the regulation of key signaling pathways, including the MAPK and PI3K/AKT pathways. However, further in vivo studies are needed to validate these findings and assess its safety profile.
The compound's bioavailability and pharmacokinetic properties are currently under investigation. Early results suggest that it has moderate solubility and permeability, which may necessitate formulation strategies to enhance its delivery. Researchers are exploring nanoparticle-based delivery systems and prodrug approaches to improve its therapeutic efficacy.
In conclusion, 1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)- (CAS: 39115-22-5) represents a promising candidate for further development in the pharmaceutical and chemical biology fields. Its multifaceted biological activities, combined with advances in synthetic and analytical methodologies, position it as a valuable molecule for future research. Continued efforts to elucidate its mechanisms of action and optimize its therapeutic potential are expected to yield significant contributions to the field.
39115-22-5 (1,2-Butanediol, 4-(4-hydroxy-3-methoxyphenyl)-) Related Products
- 26509-45-5(1,2-Propanediol,3-(3,4-dimethoxyphenyl)-)
- 22805-15-8(3-(4-Hydroxy-3,5-dimethoxyphenyl)propane-1,2-diol)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)